Fatty Liver Disease: Metabolic, Genetic, or Both?
作者信息
Zoller Heinz, Wagner Sonja, Schaefer Benedikt
机构信息
Department of Medicine Medical University of Innsbruck Innsbruck Austria.
Christian Doppler Laboratory of Iron and Phosphate Biology Medical University of Innsbruck Innsbruck Austria.
出版信息
Hepatol Commun. 2020 Sep 3;4(9):1239-1241. doi: 10.1002/hep4.1598. eCollection 2020 Sep.
Abstract
摘要
相似文献
1
Fatty Liver Disease: Metabolic, Genetic, or Both?
Hepatol Commun. 2020 Sep 3;4(9):1239-1241. doi: 10.1002/hep4.1598. eCollection 2020 Sep.
2
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.非酒精性脂肪性肝病：代谢综合征的前驱病变
Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18.
3
NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.载脂蛋白 L1、TM6SF2、GCKR 和 LYPLAL1 中的非酒精性脂肪性肝病风险等位基因显示出不同的代谢效应。
Hum Mol Genet. 2018 Jun 15;27(12):2214-2223. doi: 10.1093/hmg/ddy124.
4
[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies].[脂肪性肝病的继发原因——发病机制、诊断及治疗策略的最新进展]
Dtsch Med Wochenschr. 2020 Feb;145(3):140-145. doi: 10.1055/a-0965-9648. Epub 2020 Feb 4.
5
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.系统评价：多囊卵巢综合征与代谢综合征和非酒精性脂肪性肝病的关系。
Aliment Pharmacol Ther. 2011 Apr;33(7):801-14. doi: 10.1111/j.1365-2036.2011.04579.x. Epub 2011 Jan 20.
6
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants.非酒精性脂肪性肝病、代谢综合征与含patatin样磷脂酶结构域蛋白3基因变异体
Eur J Intern Med. 2014 Jul;25(6):566-70. doi: 10.1016/j.ejim.2014.05.012. Epub 2014 Jun 16.
7
[Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].[非酒精性脂肪性肝病作为代谢综合征的一个组成部分及其与其他肝外疾病的因果关系]
Orv Hetil. 2017 Dec;158(52):2051-2061. doi: 10.1556/650.2017.30936.
8
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.非酒精性脂肪性肝病的流行病学影响因素：聚焦高危人群。
Dig Liver Dis. 2015 Dec;47(12):997-1006. doi: 10.1016/j.dld.2015.08.004. Epub 2015 Aug 14.
9
Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.《生命线研究中非酒精性脂肪性肝病的患病率及影响因素：一项大型荷兰人群队列研究》
PLoS One. 2017 Feb 2;12(2):e0171502. doi: 10.1371/journal.pone.0171502. eCollection 2017.
10
Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease.脂肪肝指数和脂质蓄积产物可预测无脂肪肝疾病受试者的代谢综合征。
Gastroenterol Res Pract. 2017;2017:9279836. doi: 10.1155/2017/9279836. Epub 2017 Jan 17.
本文引用的文献
1
Genome-Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study.肝脏脂肪的全基因组关联研究：多民族队列肥胖表型研究
Hepatol Commun. 2020 Jun 25;4(8):1112-1123. doi: 10.1002/hep4.1533. eCollection 2020 Aug.
2
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.代谢相关脂肪性肝病新定义：国际专家共识声明。
J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8.
3
PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease.PNPLA3——慢性肝病个性化治疗的潜在治疗靶点。
Front Med (Lausanne). 2019 Dec 17;6:304. doi: 10.3389/fmed.2019.00304. eCollection 2019.
4
Toward More Accurate Nomenclature for Fatty Liver Diseases.迈向更准确的脂肪性肝病命名法
Gastroenterology. 2019 Sep;157(3):590-593. doi: 10.1053/j.gastro.2019.05.064. Epub 2019 May 31.
5
GWAS for BMI: a treasure trove of fundamental insights into the genetic basis of obesity.GWAS 研究体重指数：探索肥胖遗传基础的宝贵资源。
Int J Obes (Lond). 2018 Aug;42(8):1524-1531. doi: 10.1038/s41366-018-0147-5. Epub 2018 Jul 6.
6
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.一种截短蛋白的HSD17B13变体与慢性肝病的防护
N Engl J Med. 2018 Mar 22;378(12):1096-1106. doi: 10.1056/NEJMoa1712191.
7
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
8
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
9
The diagnosis of exclusion: an ongoing uncertainty.排除性诊断：持续存在的不确定性。
Tex Heart Inst J. 2013;40(4):379-81.
10
Secondary causes of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的继发原因。
Therap Adv Gastroenterol. 2012 May;5(3):199-207. doi: 10.1177/1756283X11430859.
Zotero 插件